(Q34023948)

30 July 2017

1 reference

title

Geriatric oncology: challenges for the new century (English)

1 reference

30 July 2017

Balducci L

1

1 reference

30 July 2017

1 September 2000

1 reference

European Journal of Cancer

30 July 2017

1 reference

30 July 2017

36

1 reference

30 July 2017

1741-1754

1 reference

30 July 2017

14

1 reference

Aging and cancer in America. Demographic and epidemiologic perspectives

30 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900169-6

7 January 2021

The family caregiver of the older cancer patient.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900169-6

7 January 2021

Diagnosis of illness presentation in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900169-6

7 January 2021

Perspectives on quality of life of older patients with cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900169-6

7 January 2021

A randomized clinical trial of outpatient comprehensive geriatric assessment coupled with an intervention to increase adherence to recommendations

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900169-6

7 January 2021

Management of cancer in the older person: a practical approach

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900169-6

7 January 2021

The process of care in preventive in-home comprehensive geriatric assessment

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900169-6

7 January 2021

Cancer and aging. An evolving panorama

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900169-6

7 January 2021

Cancer screening in the elderly population

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900169-6

7 January 2021

Integrating geriatrics into clinical training, research training, board certification, and continuing education in infectious diseases: meeting review and commentary

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900169-6

7 January 2021

Chemoprevention of breast cancer in the older patient

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900169-6

7 January 2021

Hemopoietic reserve in the older cancer patient: clinical and economic considerations

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900169-6

7 January 2021

The conquest of cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900169-6

7 January 2021

Assessment of the older cancer patient

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900169-6

7 January 2021

Measuring comorbidity in older cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900169-6

7 January 2021

The effect of comorbidity on 3-year survival of women with primary breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900169-6

7 January 2021

Disease, Disability, and Age in Cognitively Intact Seniors: Results From the Canadian Study of Health and Aging

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900169-6

7 January 2021

Interleukin-6: a cytokine for gerontologists

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900169-6

7 January 2021

National Institutes of Health Consensus Development Conference Statement: geriatric assessment methods for clinical decision-making

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900169-6

7 January 2021

A multicomponent intervention to prevent delirium in hospitalized older patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900169-6

7 January 2021

A multifactorial intervention to reduce the risk of falling among elderly people living in the community

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900169-6

7 January 2021

Cancer in the frail patient. A coming epidemic

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900169-6

7 January 2021

A brief clinical instrument to classify frailty in elderly people

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900169-6

7 January 2021

Importance of functional measures in predicting mortality among older hospitalized patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900169-6

7 January 2021

Value of functional status as a predictor of mortality: results of a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900169-6

7 January 2021

Functional impairment in instrumental activities of daily living: an early clinical sign of dementia?

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900169-6

7 January 2021

Validation of a multidimensional evaluation scale for use in elderly cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900169-6

7 January 2021

Prevalence of co-morbidity in newly diagnosed patients with cancer: a population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900169-6

7 January 2021

Validation of a measure of physical illness burden at autopsy: the Cumulative Illness Rating Scale

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900169-6

7 January 2021

Relation between cognitive impairment and early death in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900169-6

7 January 2021

The effects of cognitive impairment on 9-year mortality in a community sample.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900169-6

7 January 2021

Psychiatric status and 9-year mortality data in the New Haven Epidemiologic Catchment Area Study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900169-6

7 January 2021

Depressive symptoms and 3-year mortality in older hospitalized medical patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900169-6

7 January 2021

Factors associated with six-month mortality in recipients of community-based long-term care.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900169-6

7 January 2021

Assessing life expectancies of older nursing home residents.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900169-6

7 January 2021

A practical approach to identifying mortality-related factors in established long-term care residents.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900169-6

7 January 2021

Food intake and mortality in the frail elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900169-6

7 January 2021

Key features of maltreatment of the infirm elderly in home settings

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900169-6

7 January 2021

A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900169-6

7 January 2021

Are Performance-Based Measures Sufficiently Reliable for Use in Multicenter Trials?

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900169-6

7 January 2021

Midlife hand grip strength as a predictor of old age disability

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900169-6

7 January 2021

The relative importance of strength and balance in chair rise by functionally impaired older individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900169-6

7 January 2021

Development of a physical performance and mobility examination

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900169-6

7 January 2021

Screening for frailty: criteria and predictors of outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900169-6

7 January 2021

Toward an understanding of frailty

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900169-6

7 January 2021

Air pollution and lung cancer in Trieste, Italy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900169-6

7 January 2021

Molecular interactions of cancer and age.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900169-6

7 January 2021

Telomeres and senescence: ending the debate

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900169-6

7 January 2021

Acute myelogenous leukemia and aging. Clinical interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900169-6

7 January 2021

Prognostic value of serum interleukin-6 in diffuse large-cell lymphoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900169-6

7 January 2021

Breast cancer and aging. Clinical interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900169-6

7 January 2021

Cancer screening in the older patient.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900169-6

7 January 2021

Continuing screening mammography in women aged 70 to 79 years: impact on life expectancy and cost-effectiveness

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900169-6

7 January 2021

Cancer surgery in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900169-6

7 January 2021

Cancer surgery in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900169-6

7 January 2021

Radiation therapy of the older patient

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900169-6

7 January 2021

Radiotherapy in the aged.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900169-6

7 January 2021

Antineoplastic chemotherapy of the older cancer patient

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900169-6

7 January 2021

Management of the frail person with advanced cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900169-6

7 January 2021

Erythropoietin addition to granulocyte colony-stimulating factor abrogates life-threatening neutropenia and increases peripheral-blood progenitor-cell mobilization after epirubicin, paclitaxel, and cisplatin combination chemotherapy: results of a ra

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900169-6

7 January 2021

Adaptive control of etoposide administration: impact of interpatient pharmacodynamic variability.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900169-6

7 January 2021

First-cycle blood counts and subsequent neutropenia, dose reduction, or delay in early-stage breast cancer therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900169-6

7 January 2021

Cyclophosphamide, methotrexate, and 5-fluorouracil chemotherapy in women more than 65 years old with advanced breast cancer: the elimination of age trends in toxicity by using doses based on creatinine clearance

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900169-6

7 January 2021

Persistence of cisplatin-induced DNA interstrand crosslinking in peripheral blood mononuclear cells from elderly and young individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900169-6

7 January 2021

Age and sex are independent predictors of 5-fluorouracil toxicity. Analysis of a large scale phase III trial

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900169-6

7 January 2021

Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900169-6

7 January 2021

Risk factors for high-dose cytarabine neurotoxicity: an analysis of a cancer and leukemia group B trial in patients with acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900169-6

7 January 2021

Chemotherapy of metastatic breast cancer in the elderly. The Piedmont Oncology Association experience [see comment].

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900169-6

7 January 2021

Cancer treatment and age: patient perspectives

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900169-6

7 January 2021

Treatment tolerance of elderly cancer patients entered onto phase II clinical trials: an Illinois Cancer Center study.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900169-6

7 January 2021

Comparison of doxorubicin and mitoxantrone in the treatment of elderly patients with advanced diffuse non-Hodgkin's lymphoma using CHOP versus CNOP chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900169-6

7 January 2021

Elderly patients with aggressive non-Hodgkin's lymphoma treated with CHOP chemotherapy plus granulocyte-macrophage colony-stimulating factor: identification of two age subgroups with differing hematologic toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900169-6

7 January 2021

CHOP is the standard regimen in patients > or = 70 years of age with intermediate-grade and high-grade non-Hodgkin's lymphoma: results of a randomized study of the European Organization for Research and Treatment of Cancer Lymphoma Cooperative Study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900169-6

7 January 2021

Elderly patients with aggressive non-Hodgkin's lymphoma: disease presentation, response to treatment, and survival--a Groupe d'Etude des Lymphomes de l'Adulte study on 453 patients older than 69 years

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900169-6

7 January 2021

The treatment of elderly patients with aggressive non-Hodgkin's lymphomas: feasibility and efficacy of an intensive multidrug regimen

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900169-6

7 January 2021

In search of an optimal regimen for elderly patients with advanced-stage diffuse large-cell lymphoma: results of a phase II study of P/DOCE chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900169-6

7 January 2021

Aggressive Chemotherapy for Diffuse Histiocytic Lymphoma in the Elderly: Increased Complications with Advancing Age

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900169-6

7 January 2021

Cancer Care in the Elderly: Cost and Quality-of-Life Considerations.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900169-6

7 January 2021

10.1016/S0959-8049(00)00169-6

Identifiers

DOI

1 reference

release_2v6gs4mgtvdmhf5rhitkgv5ax4

30 July 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/2v6gs4mgtvdmhf5rhitkgv5ax4

24 November 2022

mapped directly with Wikidata item

PubMed ID

10974621

1 reference

PubMed ID

10974621